Agents Indication Reference
Everolimus + Gemcitabine or Paclitaxel Non-Hodgkin's Lymphoma [59]
Daunorubicin + Cytarabine + Zosquidar Angiomyolipoma [61]
Mitomycin C + Methotrexate + Taxanes Breast cancer [62]
5-Fluorouracil + Leucovorin Colon cancer [224]
Paclitaxel + Carboplatin Non-small-cell lung cancer [225]
Exemestane + Zoledronic acid Breast cancer [56]
Table 2: Combination MTIs currently undergoing preclinical and clinical trials.